INVOLVEMENT OF THE MACROPHAGE LOW-DENSITY-LIPOPROTEIN RECEPTOR-BINDING DOMAINS IN THE UPTAKE OF OXIDIZED LOW-DENSITY-LIPOPROTEIN

被引:25
作者
KEIDAR, S
BROOK, GJ
ROSENBLAT, M
FUHRMAN, B
DANKNER, G
AVIRAM, M
机构
[1] RAMBAM MED CTR,LIPID RES LAB,HAIFA,ISRAEL
[2] TECHNION ISRAEL INST TECHNOL,FAC MED,RAPPOPORT INST RES MED SCI,HAIFA,ISRAEL
来源
ARTERIOSCLEROSIS AND THROMBOSIS | 1992年 / 12卷 / 04期
关键词
OXIDIZED LOW DENSITY LIPOPROTEINS; MONOCLONAL ANTIBODIES; MACROPHAGES;
D O I
10.1161/01.ATV.12.4.484
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Macrophages, unlike most other cells, possess both low density lipoprotein (LDL) and scavenger receptors. The scavenger receptor has been shown to mediate the uptake of oxidized LDL (ox-LDL), which ultimately leads to cholesterol loading of the macrophages. The present study was undertaken to define epitopes on ox-LDL that are important for lipoprotein binding to macrophages and to ascertain whether ox-LDL can bind to the LDL receptor. Monoclonal antibodies (Mabs) directed against several epitopes along the apolipoprotein B-100 (apo B-100) molecule were used. LDL (300-mu-g/ml) was oxidized by incubation with 10-mu-M CuSO4 for 24 hours. Ox-LDL, as opposed to acetylated LDL (ac-LDL), reacted with Mabs directed against the LDL receptor-binding domains (Mabs B1B6 and B1B3. Similarly, uptake of ox-LDL but not ac-LDL by a murine J774 macrophage-like cell line was inhibited by as much as 40% after using Mab B1B6. The anti-LDL receptor antibody IgG-C7 also inhibited I-125-ox-LDL uptake by macrophages by 60%. Chromatography on heparin-Sepharose columns of LDL that was partially oxidized for only 3 hours resulted in two fractions: an unbound fraction with characteristics similar to those of ox-LDL and a bound fraction similar to native LDL. Macrophage degradation of the unbound fraction was inhibited by Mab IgG-C7 and Mab B1B6, which are directed toward the LDL receptor and the LDL receptor-binding domains on apo B-100, respectively. When incubated with three types of macrophages, J774 macrophage cells, mouse peritoneal macrophages, and human monocyte-derived macrophages, excess amounts of unlabeled ox-LDL, like native LDL but unlike ac-LDL, substantially suppressed the uptake and degradation of I-125-labeled LDL Similar studies with fibroblasts, however, revealed that unlabeled LDL but not unlabeled ox-LDL or ac-LDL competed with I-125-LDL for cellular uptake and degradation. Mab directed against epitopes on the amino terminus domain of apo B-100 (C14) demonstrates a similar immunoreactivity with ox-LDL and native LDL but a much lower reactivity with ac-LDL Mab C14 inhibited macrophage degradation of ox-LDL by 34% but had no inhibitory effect on the uptake of native LDL or ac-LDL. Thus, the ac-LDL and LDL receptor-binding domains as well as a unique epitope on the amino terminus of apo B-100 may be involved in macrophage binding of ox-LDL We conclude that 1) ox-LDL contains epitopes that are also present in native LDL, although considerable changes in these epitopes are suggested and 2) these epitopes are involved in the uptake of ox-LDL by macrophages.
引用
收藏
页码:484 / 493
页数:10
相关论文
共 46 条
[1]   MULTIPLE RECEPTORS FOR MODIFIED LOW-DENSITY LIPOPROTEINS IN MOUSE PERITONEAL-MACROPHAGES - DIFFERENT UPTAKE MECHANISMS FOR ACETYLATED AND OXIDIZED LOW-DENSITY LIPOPROTEINS [J].
ARAI, H ;
KITA, T ;
YOKODE, M ;
NARUMIYA, S ;
KAWAI, C .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 159 (03) :1375-1382
[2]   PLATELET SECRETORY PRODUCTS INCREASE LOW-DENSITY-LIPOPROTEIN OXIDATION, ENHANCE ITS UPTAKE BY MACROPHAGES, AND REDUCE ITS FLUIDITY [J].
AVIRAM, M ;
DANKNER, G ;
BROOK, JG .
ARTERIOSCLEROSIS, 1990, 10 (04) :559-563
[3]   PLASMA-LIPOPROTEIN SEPARATION BY DISCONTINUOUS DENSITY GRADIENT ULTRA-CENTRIFUGATION IN HYPERLIPOPROTEINEMIC PATIENTS [J].
AVIRAM, M .
BIOCHEMICAL MEDICINE, 1983, 30 (01) :111-118
[4]  
AVIRAM M, 1988, J BIOL CHEM, V263, P15416
[5]   LOW-DENSITY LIPOPROTEIN AND SCAVENGER RECEPTOR ACTIVITIES ARE MODULATED BY SECRETORY PRODUCTS DERIVED FROM CELLS OF THE ARTERIAL-WALL [J].
AVIRAM, M .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1989, 38 (05) :445-449
[6]  
AVIRAM M, 1988, J BIOL CHEM, V263, P16842
[7]  
AVIRAM M, 1991, J BIOL CHEM, V266, P11567
[8]  
AVIRAM M, 1992, J BIOL CHEM, V267, P218
[9]  
AVIRAM M, 1991, BLOOD CELL BIOCH, V2, P179
[10]   METABOLISM OF VERY LOW-DENSITY LIPOPROTEIN PROTEINS .1. PRELIMINARY IN-VITRO AND IN-VIVO OBSERVATIONS [J].
BILHEIMER, DW ;
LEVY, RI ;
EISENBERG, S .
BIOCHIMICA ET BIOPHYSICA ACTA, 1972, 260 (02) :212-+